Could PMI's (PM) US Investment in Smoke-Free Products Redefine Its Long-Term Growth Strategy?

• Philip Morris International’s U.S. businesses recently announced a US$37 million investment to expand their manufacturing facility in Wilson, North Carolina, adding a production line for TEREA to support the IQOS ILUMA heated tobacco system, pending FDA approval.
• This expansion is part of a broader US manufacturing strategy, reflecting a significant shift toward producing smoke-free alternatives while reinforcing PMI’s long-term commitment to American manufacturing and innovation.
• We’ll examine how PMI’s increased investment in US production for smoke-free products could reshape the company’s long-term growth outlook.

Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

Philip Morris International Investment Narrative Recap

To own shares of Philip Morris International, you need to believe that the company’s shift toward smoke-free alternatives will sustainably offset pressures from ongoing declines in cigarette sales and enable stable long-term returns. The recent US$37 million Wilson, North Carolina expansion is a step in that direction but does not change the fact that FDA authorization for the IQOS ILUMA system remains the most important near-term catalyst, while regulatory and tax risks continue to be the biggest headwinds. If FDA approvals or market adoption disappoint, the impact on the company’s transformation could be material.

The 8.9% dividend increase announced in September 2025 may be the most relevant recent event for shareholders tracking total return, reinforcing PMI’s ability to return capital even as it increases smoke-free investments. Dividend sustainability alongside ambitious product rollouts hinges on successful growth and regulatory differentiation for reduced-risk products, heightening the significance of PMI’s regulatory progress for IQOS ILUMA in the United States.

On the other hand, investors should also be mindful of how...

Read the full narrative on Philip Morris International (it's free!)

Philip Morris International's outlook anticipates $49.4 billion in revenue and $14.5 billion in earnings by 2028. This is based on a projected 8.2% annual revenue growth rate and an increase in earnings of $6.3 billion from the current $8.2 billion.

Uncover how Philip Morris International's forecasts yield a $190.20 fair value, a 24% upside to its current price.

Exploring Other Perspectives

While recent developments may fuel optimism, the lowest analyst estimates point to future annual revenues of US$47.1 billion and earnings of US$14.4 billion by 2028, but warn that tightening regulations and rising costs could sharply impact margins and slow progress. Your views might differ, take a look at how forecasts and risks stack up to make your own call.

Explore 10 other fair value estimates on Philip Morris International - why the stock might be worth as much as 43% more than the current price!

Build Your Own Philip Morris International Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Philip Morris International research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Philip Morris International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Philip Morris International's overall financial health at a glance.

Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com